Gangolli, V.H. et al. 2025. Cobenfy: An FDA-Approved Novel Treatment for Schizophrenia. Junior Researchers. 3, 1 (Jul. 2025), 88–92. DOI:https://doi.org/10.52340/jr.2025.03.01.07.